Pediatric Dosing of Cefdinir for UTI in a 33 kg Child
For a 33 kg pediatric patient with a urinary tract infection, the recommended dose of cefdinir is 14 mg/kg/day divided into one or two daily doses, which equals approximately 462 mg/day (either as 231 mg twice daily or 462 mg once daily) for 7-14 days. 1
Dosing Considerations
- Cefdinir is an oral third-generation cephalosporin with good activity against common urinary tract pathogens 1
- For pediatric patients, the standard dosing is 14 mg/kg/day, which can be administered as:
- Once-daily dosing: 14 mg/kg once daily (462 mg for a 33 kg child)
- Twice-daily dosing: 7 mg/kg twice daily (231 mg twice daily for a 33 kg child) 1
Duration of Therapy
- The recommended duration for treating UTIs in pediatric patients is 7-14 days 2
- Shorter courses (1-3 days) have been shown to be inferior for febrile UTIs 2
Efficacy for UTIs
- Cefdinir has demonstrated 95.6% susceptibility against common urinary pathogens in pediatric patients, including Escherichia coli, Klebsiella spp, and Proteus spp 3
- This susceptibility rate is comparable or superior to many other commonly used antibiotics for UTIs:
- Ampicillin (49.4%)
- Trimethoprim-sulfamethoxazole (84.9%)
- Cefazolin (88.4%)
- Nitrofurantoin (93.3%)
- Ticarcillin-clavulanate (94.2%)
- Gentamicin (97.5%)
- Ceftriaxone (97.7%) 3
Alternative Options for UTIs in Pediatric Patients
If cefdinir is unavailable or contraindicated, other empiric oral options include:
- Amoxicillin-clavulanate: 20-40 mg/kg/day divided into 3 doses 2
- Cefixime: 8 mg/kg/day as a single dose 2
- Cefpodoxime: 10 mg/kg/day divided into 2 doses 2
- Cefprozil: 30 mg/kg/day divided into 2 doses 2
- Cephalexin: 50-100 mg/kg/day divided into 4 doses 2
Important Clinical Considerations
- Cefdinir has shown good distribution in tissues and fluids, with a pharmacokinetic profile allowing once or twice daily administration 1
- The oral suspension formulation has demonstrated superior palatability compared to other oral antimicrobial agents, which may improve adherence in pediatric patients 1
- For patients who appear toxic or unable to tolerate oral medications, consider initial parenteral therapy until clinical improvement occurs (typically within 24-48 hours) 2
- Local antimicrobial sensitivity patterns should guide empiric therapy choices, with adjustment based on culture results when available 2